Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies

Courtney D. DiNardo, Michael R. Savona, Ashwin Kishtagari, Amir T. Fathi, Kapil N. Bhalla, Samuel Agresta, Sarah Reilly, Caroline Almon, Murphy Hentemann, Denice Hickman, Dillon Corrigan, Meghan Macaraeg, Jessica Piel, Kim Horrigan, Salah Nabhan, Paul Martin, Eytan M. Stein

Blood (2023) 142 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2023-178090

Published: 2023

Journal Articles

Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

Blood (2023) 141 (21): 2576–2586.

https://doi.org/10.1182/blood.2022019254

Published: 2023

Includes: Supplemental data

Journal Articles

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Nicole Thomas, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, Nancy L. Bartlett, Jeffrey Bethony, Kishor Bhatia, Jay Bowen, Anthony C. Bryan, Ethel Cesarman, Corey Casper, Amy Chadburn, Manuela Cruz, Dirk P. Dittmer, Maureen A. Dyer, Pedro Farinha, Julie M. Gastier-Foster, Alina S. Gerrie, Bruno M. Grande, Timothy Greiner, Nicholas B. Griner, Thomas G. Gross, Nancy L. Harris, John D. Irvin, Elaine S. Jaffe, David Henry, Rebecca Huppi, Fabio E. Leal, Michael S. Lee, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Ronald Mitsuyasu, Vivian Morris, Charles G. Mullighan, Andrew J. Mungall, Karen Mungall, Innocent Mutyaba, Mostafa Nokta, Constance Namirembe, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, German Ott, Hilary Petrello, Stefania Pittaluga, James D. Phelan, Juan Carlos Ramos, Lee Ratner, Steven J. Reynolds, Paul G. Rubinstein, Gerhard Sissolak, Graham Slack, Shaghayegh Soudi, Steven H. Swerdlow, Alexandra Traverse-Glehen, Wyndham H. Wilson, Jasper Wong, Robert Yarchoan, Jean C. ZenKlusen, Marco A. Marra, Louis M. Staudt, David W. Scott, Ryan D. Morin

Blood (2023) 141 (8): 904–916.

https://doi.org/10.1182/blood.2022016534

Published: 2023

Includes: Supplemental data

Journal Articles

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Blood (2022) 140 (Supplement 1): 1734–1736.

https://doi.org/10.1182/blood-2022-163728

Published: 2022

Journal Articles

Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma

Blood (2021) 138 (Supplement 1): 806.

https://doi.org/10.1182/blood-2021-147916

Published: 2021

Journal Articles

Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness

Mohamad Mohty, Ernst Holler, Madan Jagasia, Robert Jenq, Florent Malard, Paul Martin, Gérard Socié, Robert Zeiser

Blood (2020) 136 (17): 1903–1906.

https://doi.org/10.1182/blood.2020007336

Published: 2020

Journal Articles

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Bruno M. Grande, Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, Leona W. Ayers, Jeffrey M. Bethony, Kishor Bhatia, Jay Bowen, Corey Casper, John Kim Choi, Luka Culibrk, Tanja M. Davidsen, Maureen A. Dyer, Julie M. Gastier-Foster, Patee Gesuwan, Timothy C. Greiner, Thomas G. Gross, Benjamin Hanf, Nancy Lee Harris, Yiwen He, John D. Irvin, Elaine S. Jaffe, Steven J. M. Jones, Patrick Kerchan, Nicole Knoetze, Fabio E. Leal, Tara M. Lichtenberg, Yussanne Ma, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Charles G. Mullighan, Andrew J. Mungall, Constance Namirembe, Karen Novik, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, Steven J. Reynolds, Christopher K. Rushton, John T. Sandlund, Roland Schmitz, Cynthia Taylor, Wyndham H. Wilson, George W. Wright, Eric Y. Zhao, Marco A. Marra, Ryan D. Morin, Louis M. Staudt

Blood (2019) 133 (12): 1313–1324.

https://doi.org/10.1182/blood-2018-09-871418

Published: 2019

Includes: Supplemental data

Journal Articles

An Assay for Simultaneous Profiling of Gene Expression, Phospho- and Total Protein Abundance, and Somatic DNA Mutations for Hematology-Oncology Research

Blood (2017) 130 (Supplement 1): 2481.

https://doi.org/10.1182/blood.V130.Suppl_1.2481.2481

Published: 2017

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Blood (2017) 130 (Supplement 1): 39.

https://doi.org/10.1182/blood.V130.Suppl_1.39.39

Published: 2017

Journal Articles

Interferon-γ Induces Distinct mRNA and Protein Profiles in Acute and Chronic Myeloid Leukemia

Jayakumar Vadakekolathu, PhD, Rhonda Meredith, BSc, Paul Martin Ross, BSc, BA, Sarah Wagner, BSc MSc, Stephen Reeder, BSc, Gokhan Demirkan, PhD, Jamie R. Kuhar, PhD, Graham R. Ball, PhD, A. Graham Pockley, PhD, Sergio Rutella, MDPhDFRCPath

Blood (2017) 130 (Supplement 1): 3945.

https://doi.org/10.1182/blood.V130.Suppl_1.3945.3945

Published: 2017

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Daniela S Gerhard, PhD, Bruno Grande, B. Sc., Nicholas Griner, PhD, Corey Casper, MD, Sarah E. Gerdts, MPH, Abraham Omoding, MD, Jackson Orem, MD, Sam M Mbulaiteye, MD, Martin D. Ogwang, MD, Steven J. Reynolds, MD MPH, Kishor Bhatia, PhD, Leona Ayers, MD, John K Choi, MD, Charles G. Mullighan, MBBS, MSc, PhD, John T. Sandlund, MD, Thomas B. Alexander, MD MPH, Jeremy S. Abramson, MD, Thomas G. Gross, MD PhD, Ariela Noy, MD PhD, Jeffrey Bethony, PhD, Fabio Leal, MD, PhD, Timothy C Greiner, MS, MD, Elaine S. Jaffe, MD, Nancy Lee Harris, MD, Julie M. Gastier-Foster, PhD, Jay Bowen, MS, Benjamin Hanf, Roland Schmitz, PhD, Jean-Paul Martin, MD, Marie-Reine Martin, MD, John D. Irvin, MD PhD, Ellen Miller, MS, Patee Gesuwan, Leandro C. Hermida, Tanja M. Davidsen, PhD, Andrew J. Mungall, Yussanne Ma, PhD, Marco A. Marra, PhD, Ryan D. Morin, Louis M. Staudt, MD PhD

Blood (2016) 128 (22): 1760.

https://doi.org/10.1182/blood.V128.22.1760.1760

Published: 2016

Journal Articles

Impact Of Total Nucleated Cell and CD34+ Cell Dose On Transplant Related Outcomes In Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplants

Paul Martin, MD, Shuli Li, Edwin P. Alyea, MD, Vincent T. Ho, MD, Corey S. Cutler, MD, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Chance J Luckey, MD PhD, Grace Kao, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2013) 122 (21): 2048.

https://doi.org/10.1182/blood.V122.21.2048.2048

Published: 2013

Journal Articles

A Phase 3 Randomized, Historically-Controlled Clinical Trial Investigating the Use of Defibrotide in the Treatment of Severe Veno-Occlusive Disease Post-SCT: A Novel Approach to the Validation of a Promising New Drug for the Treatment of a Life Threatening Disease.

Paul Richardson, Nancy Kernan, Marcie Tomblyn, Paul Martin, Sally Arai, Joel Brochstein, Eva Guinan, Gideon Steinbach, Elizabeth Nemecek, Ralph D’Agostino, Carolyn Revta, Alison Hannah, Massimo Iacobelli, Robert Soiffer

Blood (2007) 110 (11): 614.

https://doi.org/10.1182/blood.V110.11.614.614

Published: 2007

Journal Articles

Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival.

Mary E.D. Flowers, Barry Storer, Paul Carpenter, Afonso Vigorito, Paulo Campregher, Carina Moravec, Hans-Peter Kiem, Fero Matthew, George Georges, Edus Warren, Stephanie Lee, Jean Sanders, Paul Martin

Blood (2007) 110 (11): 833.

https://doi.org/10.1182/blood.V110.11.833.833

Published: 2007

Journal Articles

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Marco Mielcarek, MD, Lauri Burroughs, MD, Wendy Leisenring, PhD, Paul Martin, MD, Razvan Diaconezcu, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, PhD, Michael Maris, MD, Judith Shizuru, MD, Karl Blume, MD, Ute Hegenbart, MD, Dietger Niederwieser, MD, Stephen Forman, MD, Benedetto Bruno, MD, Ann Woolfrey, MD, Rainer Storb, MD

Blood (2004) 104 (11): 423.

https://doi.org/10.1182/blood.V104.11.423.423

Published: 2004

Journal Articles

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

Jerald P. Radich, Ted Gooley, William Bensinger, Thomas Chauncey, Reginald Clift, Mary Flowers, Paul Martin, John Slattery, Debbie Sultan, Frederick R. Appelbaum

Blood (2003) 102 (1): 31–35.

https://doi.org/10.1182/blood-2002-08-2619

Published: 2003

Journal Articles

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

Kieren A. Marr, Rachel A. Carter, Michael Boeckh, Paul Martin, Lawrence Corey

Blood (2002) 100 (13): 4358–4366.

https://doi.org/10.1182/blood-2002-05-1496

Published: 2002

Journal Articles

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

Paul A. Carpenter, Frederick R. Appelbaum, Lawrence Corey, H. Joachim Deeg, Kris Doney, Theodore Gooley, James Krueger, Paul Martin, Sandra Pavlovic, Jean Sanders, John Slattery, Daniel Levitt, Rainer Storb, Ann Woolfrey, Claudio Anasetti

Blood (2002) 99 (8): 2712–2719.

https://doi.org/10.1182/blood.V99.8.2712

Published: 2002

Journal Articles

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

Ann E. Woolfrey, Claudio Anasetti, Barry Storer, Kristine Doney, Laurie A. Milner, Eric L. Sievers, Paul Carpenter, Paul Martin, Effie Petersdorf, Frederick R. Appelbaum, John A. Hansen, Jean E. Sanders

Blood (2002) 99 (6): 2002–2008.

https://doi.org/10.1182/blood.V99.6.2002

Published: 2002

Journal Articles

Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation

Jan Storek, Ansamma Joseph, German Espino, Monja A. Dawson, Daniel C. Douek, Keith M. Sullivan, Mary E. D. Flowers, Paul Martin, George Mathioudakis, Richard A. Nash, Rainer Storb, Frederick R. Appelbaum, David G. Maloney

Blood (2001) 98 (13): 3505–3512.

https://doi.org/10.1182/blood.V98.13.3505

Published: 2001

NARROW

Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies

Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma

Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

An Assay for Simultaneous Profiling of Gene Expression, Phospho- and Total Protein Abundance, and Somatic DNA Mutations for Hematology-Oncology Research

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Interferon-γ Induces Distinct mRNA and Protein Profiles in Acute and Chronic Myeloid Leukemia

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Impact Of Total Nucleated Cell and CD34+ Cell Dose On Transplant Related Outcomes In Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplants

A Phase 3 Randomized, Historically-Controlled Clinical Trial Investigating the Use of Defibrotide in the Treatment of Severe Veno-Occlusive Disease Post-SCT: A Novel Approach to the Validation of a Promising New Drug for the Treatment of a Life Threatening Disease.

Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival.

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only